A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Masimo Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 29,800 shares of MASI stock, worth $5.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,800
Previous 25,200 18.25%
Holding current value
$5.15 Million
Previous $3.17 Million 25.15%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$104.79 - $133.77 $3.98 Million - $5.08 Million
-37,941 Reduced 16.68%
189,549 $25.3 Million
Q2 2024

Aug 14, 2024

SELL
$115.24 - $144.91 $129 Million - $162 Million
-1,117,726 Reduced 83.09%
227,490 $28.7 Million
Q1 2024

May 15, 2024

BUY
$109.17 - $146.85 $63.4 Million - $85.3 Million
581,137 Added 76.06%
1,345,216 $198 Million
Q4 2023

Feb 14, 2024

BUY
$76.73 - $120.62 $38.9 Million - $61.2 Million
507,387 Added 197.66%
764,079 $89.6 Million
Q3 2023

Nov 14, 2023

BUY
$84.17 - $161.17 $18.3 Million - $35 Million
217,158 Added 549.29%
256,692 $22.5 Million
Q2 2023

Aug 14, 2023

SELL
$155.24 - $196.47 $18.1 Million - $22.9 Million
-116,787 Reduced 74.71%
39,534 $6.51 Million
Q1 2023

May 15, 2023

BUY
$146.03 - $184.54 $18 Million - $22.7 Million
123,109 Added 370.68%
156,321 $28.8 Million
Q4 2022

Feb 14, 2023

SELL
$110.88 - $150.36 $17.2 Million - $23.4 Million
-155,505 Reduced 82.4%
33,212 $4.91 Million
Q3 2022

Nov 14, 2022

BUY
$125.58 - $169.38 $8.01 Million - $10.8 Million
63,752 Added 51.02%
188,717 $26.6 Million
Q2 2022

Aug 15, 2022

SELL
$112.97 - $151.71 $2.43 Million - $3.26 Million
-21,490 Reduced 14.67%
124,965 $16.3 Million
Q1 2022

May 16, 2022

BUY
$135.71 - $284.87 $12.2 Million - $25.5 Million
89,531 Added 157.28%
146,455 $21.3 Million
Q4 2021

Feb 14, 2022

BUY
$266.41 - $303.29 $10.3 Million - $11.7 Million
38,669 Added 211.83%
56,924 $16.7 Million
Q3 2021

Nov 15, 2021

BUY
$249.0 - $285.24 $1.35 Million - $1.55 Million
5,437 Added 42.42%
18,255 $4.94 Million
Q2 2021

Aug 16, 2021

SELL
$208.49 - $248.2 $4.97 Million - $5.92 Million
-23,851 Reduced 65.04%
12,818 $3.11 Million
Q1 2021

May 17, 2021

BUY
$220.31 - $283.75 $6.33 Million - $8.15 Million
28,729 Added 361.83%
36,669 $8.42 Million
Q4 2020

Feb 16, 2021

SELL
$223.82 - $271.35 $2.94 Million - $3.57 Million
-13,140 Reduced 62.33%
7,940 $2.13 Million
Q2 2020

Aug 14, 2020

SELL
$178.49 - $250.39 $5.23 Million - $7.34 Million
-29,319 Reduced 58.17%
21,080 $4.81 Million
Q1 2020

May 15, 2020

BUY
$148.38 - $186.78 $7.04 Million - $8.87 Million
47,472 Added 1621.87%
50,399 $8.93 Million
Q4 2019

Feb 14, 2020

SELL
$140.81 - $159.49 $1.74 Million - $1.97 Million
-12,354 Reduced 80.85%
2,927 $463,000
Q3 2019

Nov 14, 2019

SELL
$145.61 - $159.87 $3.73 Million - $4.1 Million
-25,624 Reduced 62.64%
15,281 $2.27 Million
Q2 2019

Aug 14, 2019

SELL
$122.29 - $148.82 $55.7 Million - $67.7 Million
-455,172 Reduced 91.75%
40,905 $6.09 Million
Q1 2019

May 15, 2019

SELL
$102.78 - $138.28 $861,193 - $1.16 Million
-8,379 Reduced 1.66%
496,077 $0
Q4 2018

Feb 14, 2019

SELL
$98.38 - $125.32 $1.58 Million - $2.01 Million
-16,031 Reduced 3.08%
504,456 $54.2 Million
Q3 2018

Nov 13, 2018

SELL
$97.19 - $124.54 $24.5 Million - $31.5 Million
-252,536 Reduced 32.67%
520,487 $0
Q2 2018

Aug 10, 2018

SELL
$83.88 - $102.21 $18.2 Million - $22.2 Million
-217,306 Reduced 21.94%
773,023 $0
Q1 2018

May 11, 2018

BUY
$82.06 - $95.19 $77.3 Million - $89.7 Million
941,964 Added 1947.62%
990,329 $87.1 Million
Q4 2017

Feb 09, 2018

BUY
$84.49 - $90.09 $4.09 Million - $4.36 Million
48,365
48,365 $4.1 Million

Others Institutions Holding MASI

About MASIMO CORP


  • Ticker MASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 52,530,200
  • Market Cap $9.09B
  • Description
  • Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...
More about MASI
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.